Researchers have found that reducing the protein menin in the hypothalamus of the brain leads to the development of age-related diseases. The study found that supplementing menin levels in elderly mice led to better skin thickness, bone mass and cognitive function, while a lack of the protein led to muscle fiber reduction, tail tendon collagen cross-linking and cognitive decline. Scientists believe that a loss of menin in the hypothalamus could be the main driver behind aging in mice, and potentially in humans.

One potential intervention suggested by the study is the use of menin and D-serine supplements to reverse some aspects of aging. However, it is important to note that this study was conducted on mice and further research is needed to determine whether these findings are applicable to humans.

If you can identify people who have low menin or low D-serine levels in the hypothalamus, then you may be able to target them to see if you can reverse or at least halt some of the aging process.

Future research could investigate how menin and D-serine work together in the hypothalamus, and whether there are other factors that interact with menin and D-serine to impact the aging process. It will also be important to test whether interventions that manipulate menin or D-serine levels can delay or reverse the effects of aging in humans.

Overall, this study highlights a novel factor involved in the aging process and provides a potential avenue for future research into anti-aging interventions. While further research is needed to confirm these findings in humans, this study represents an important step forward in our understanding of aging and its underlying mechanisms.

The study discusses the role of Menin in regulating systemic aging and cognitive decline. The hypothalamus is a critical central regulator of the aging process, and neuroinflammatory signaling in the ventromedial hypothalamus (VMH) is the pace-regulator of systemic aging. However, the upstream molecules regulating neuroinflammation in the VMH are not fully understood. The study reveals that Menin plays an essential role in regulating VMH inflammation and metabolism. The authors found that VMH Menin signaling diminished in aged mice, which correlated with systemic aging and cognitive deficits. Restoring Menin expression in the VMH of aged mice extended lifespan, improved learning and memory, and ameliorated aging biomarkers. Conversely, inhibiting Menin in the VMH of middle-aged mice induced premature aging and accelerated cognitive decline. The study further discusses how Menin epigenetically regulates neuroinflammatory and metabolic pathways. Overall, the study suggests that VMH Menin serves as a key regulator of systemic aging and aging-related cognitive decline, and D-serine supplementation could be a therapeutic strategy for cognitive decline.

If the results hold up under further study, could we soon have supplements available to reverse the aging process—at least in part?